Please help TMA speed the time to diagnosis by supporting myositis awareness! Donate Now!
The Myositis Association (TMA) recognizes that the best hope for a cure for myositis diseases lies in research. Since 2002, TMA’s annual research grants program has approved 68 projects totaling nearly $8.2 million to study the underlying causes and natural progression of myositis, develop better treatments and more effective therapies, and ultimately to create a cure…
Continue Reading
Since 2002, The Myositis Association’s annual research funding program has awarded nearly $8.2 million in research support. We are pleased to announce our 2024 grant awards, funding disease-specific projects in myositis: Our first grant of $80,000 is awarded to Thomas Lloyd, MD, PhD, Chief of Neurology at Baylor College of Medicine, Houston, TX, for his…
Continue Reading
Dermatologist Dr. David Fiorentino is excited about the possibilities of cell therapies to treat autoimmune conditions like dermatomyositis (DM). In collaboration with rheumatologists and bone marrow transplant specialists at Stanford University, he is conducting a small, phase 1b clinical trial testing KYV-101, a CAR T cell therapy that targets a protein called CD19 on the…
Continue Reading
The Family and Medical Leave Act (FMLA) has long been a cornerstone of employee rights in the United States, providing eligible employees with up to 12 weeks of unpaid, job-protected leave for various family and medical reasons. In an opinion letter dated November 8, the US Department of Labor (DOL) clarified that FMLA leave can…
Continue Reading
Two important changes have been made to Medicare Part D in 2025 that may help make the cost of your prescription drugs more affordable and more manageable.
Continue Reading